You need a partner with the expertise, regulatory experience, and manufacturing capabilities to support your program as it moves through late-phase development, regulatory filing, and ultimately becomes an approved therapy.
Our Viral Vector Services team has 14+ years of experience, completed over 40 late-phase and 25 commercial lots since 2019, and is expected to receive a commercial license in 2020. We expect to receive additional licenses in 2021. Let us put our expertise and capabilities to work to advance your product from the clinic and into commercial manufacturing. Contact us to learn how we can help you with your viral vector project.
Learn more about Patheon Viral Vector Services end-to-end capabilities.